Boston life sciences and medical device leaders agreed that the change to a Trump administration could create a more ...

Ali Pashazadeh, CEO of the biotech consultancy Treehill Partners ... “I would be very cautious about being too optimistic ...

And so is Reeser, founder and CEO of a Wilmington startup that is bringing ... working with David and his OpiAID team,” said ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of ...

Emergent BioSolutions raised its revenue guidance and dropped a going concern warning. Its CEO is billing this next chapter ...

In September 2024, Cidara initiated a randomized, double-blind, controlled Phase 2b trial targeting enrollment of 5,000 healthy, unvaccinated adult subjects who are not at risk of complications from ...

The coffee chain’s new chief executive is focusing on cafe operations and company affairs as he seeks quick change.

And the two candidates headed for the runoff election — Marketing and Engineering Technologies International CEO Renard Johnson and current West Side city Rep. Brian Kennedy — represent ...

“The only currency a biotech company has is the story they tell,” said Steve Uden, CEO and co-founder of Rallybio. “We don’t ...

November 04, 2024 20:58 PM UTC - Updated November 04, 2024 20:58 PM UTC Starbucks has had four different CEOs since 2022, but board members are banking on former Chipotle CEO Brian Niccol to turn ...